financetom
Business
financetom
/
Business
/
Suspect in UnitedHealth CEO's killing faces terrorism charges in New York
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Suspect in UnitedHealth CEO's killing faces terrorism charges in New York
Dec 23, 2024 3:34 AM

*

Luigi Mangione faces 11 state charges, including murder

and

terrorism

*

Maximum NY sentence is life without parole if convicted

*

Federal charges could lead to death penalty

*

Charges based on conflicting theories, says defense lawyer

*

Mangione seen as folk hero by some for anti-healthcare

industry

stance

By Luc Cohen

NEW YORK, Dec 23 (Reuters) -

Luigi Mangione, the man suspected of fatally gunning down

UnitedHealth Group ( UNH ) chief executive Brian Thompson on a

Manhattan street, is due to be arraigned on Monday on state

murder charges that brand him a terrorist.

At the hearing in New York state court in Manhattan, Mangione is

expected to be asked to enter a plea to the 11-count indictment,

which includes three murder charges, including murder as an act

of terrorism. If convicted, he faces a maximum sentence of life

in prison without the possibility of parole.

Mangione's lawyer Karen Friedman Agnifilo declined to

comment.

It will be the second court appearance in New York for Mangione,

26, since he was arrested at a fast food restaurant in Altoona,

Pennsylvania, five days after the brazen, pre-dawn Dec. 4

killing of Thompson outside a hotel in midtown Manhattan where

his company was gathering for an investor conference.

Mangione also faces a four-count federal criminal complaint

charging him with stalking and killing Thompson. He has not yet

been asked to enter a plea to those charges. U.S. Magistrate

Judge Katharine Parker ordered Mangione detained at a Dec. 19

presentment on those charges.

The federal charges would make him eligible for the death

penalty, should the U.S. Attorney's office in Manhattan decide

to pursue it.

The separate federal and state cases will proceed in

parallel. The state case is currently expected to go to trial

first, federal prosecutors said.

Friedman Agnifilo said at the federal court hearing that the two

sets of charges appeared to be based on conflicting theories.

The state charges accuse Mangione of intending to "intimidate or

coerce a civilian population" and influence policy, while the

federal charges accuse him of stalking and killing an

individual.

Friedman Agnifilo said the two cases seemed completely

different, and she asked prosecutors to clarify whether both

would continue. Dominic Gentile, a federal prosecutor, said

Thursday's initial appearance was not the appropriate time to

address those legal arguments.

According to the federal criminal complaint, the police who

arrested Mangione found a notebook that contained several

handwritten pages that "express hostility towards the health

insurance industry and wealthy executives in particular."

A notebook entry dated Oct. 22 allegedly described an intent

to "wack" the chief executive of an insurance company at its

investor conference.

While the killing of Thompson has been broadly condemned,

Mangione has been feted as a folk hero by some Americans who

decry the steep costs of healthcare and the power held by

insurance companies to deny paying for some medical treatments.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Genuine Parts Q3 Adjusted Earnings, Net Sales Increase; 2025 Outlook Updated
Genuine Parts Q3 Adjusted Earnings, Net Sales Increase; 2025 Outlook Updated
Oct 21, 2025
07:14 AM EDT, 10/21/2025 (MT Newswires) -- Genuine Parts ( GPC ) reported Q3 adjusted earnings Tuesday of $1.98 per diluted share, up from $1.88 a year earlier. Analysts polled by FactSet expected $1.99. Net sales for the quarter ended Sept. 30 were $6.26 billion, compared with $5.97 billion a year earlier. Analysts polled by FactSet expected $6.12 billion. The...
Quest Diagnostics raises annual profit and revenue forecasts on lab test demand
Quest Diagnostics raises annual profit and revenue forecasts on lab test demand
Oct 21, 2025
Oct 21 (Reuters) - Laboratory operator Quest Diagnostics ( DGX ) raised its full-year forecast for profit and revenue on Tuesday, banking on robust demand for its diagnostic tests. Shares of the New Jersey-based company were up 2.7% in premarket trading. Quest expects 2025 adjusted profit between $9.76 and $9.84 per share versus its previous range of $9.63 to $9.83...
Capital City Bank Q3 profit rises as funding costs decline
Capital City Bank Q3 profit rises as funding costs decline
Oct 21, 2025
Overview * Capital City Bank ( CCBG ) Q3 net income rises to $16 mln, EPS at $0.93 * Net interest income for Q3 increases slightly to $43.6 mln * Noninterest income up 11.6% due to insurance subsidiary sale Outlook * Company did not provide specific guidance for future quarters or full year Result Drivers * NET INTEREST MARGIN -...
Form 8.3 - Just Group PLC
Form 8.3 - Just Group PLC
Oct 21, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved